Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Sci Rep ; 14(1): 21971, 2024 09 20.
Artigo em Inglês | MEDLINE | ID: mdl-39304685

RESUMO

We analyzed data from positively tested COVID-19 outpatients to describe self-medication with OTC drugs and use of other remedies against symptoms of SARS-CoV-2 infection. We specifically considered their type and frequency, as well as associations with patient characteristics, and reasons for use. Data were collected between May 1, 2020 and February 22, 2021 with two questionnaires in an observational cohort study with PCR-confirmed SARS-CoV-2-positive adult outpatients in the district of Western Pomerania in Germany. 523 out of 710 outpatients (74%; 340 women and 183 men) reported using drugs and other remedies to relieve COVID-19-symptoms. Overall, participants reported utilization of 1282 finished dosage products or remedies, including 213 different ingredients. In the population of 710 outpatients, utilization of ibuprofen (26%), acetaminophen (21%), metamizole (14%), and acetylsalicylic acid (10%) was most commonly reported. Phytopharmaceuticals, herbal and animal products as well as vitamins and minerals were also frequently reported. Among the 523 participants who used drugs and other remedies, most commonly mentioned reasons for use were headache (40%), other kinds of pain (e.g. myalgia; 37%), fever (24%) and cough (16%). Our analysis showed that a majority of the participants tried to alleviate COVID-19-symptoms using drugs and other remedies. Especially analgesic and antipyretic agents, followed by herbal medicines, were used very frequently.Trial registration: German Register for Clinical Studies DRKS00021672, first registration on December 1st, 2020.


Assuntos
Tratamento Farmacológico da COVID-19 , COVID-19 , Pacientes Ambulatoriais , SARS-CoV-2 , Automedicação , Humanos , Feminino , Masculino , Automedicação/estatística & dados numéricos , Alemanha/epidemiologia , Pessoa de Meia-Idade , COVID-19/epidemiologia , Adulto , Pacientes Ambulatoriais/estatística & dados numéricos , Idoso , SARS-CoV-2/isolamento & purificação , Ibuprofeno/uso terapêutico , Medicamentos sem Prescrição/uso terapêutico , Acetaminofen/uso terapêutico , Inquéritos e Questionários , Dipirona/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA